EDGE PHARMACEUTICALS LIMITED
Significant control: Geoffrey Hugh Melamet (75–100%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Edge Pharmaceuticals Limited: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
What does Edge Pharmaceuticals Limited sell?
Registered activity: Other service activities n.e.c. (SIC 96090). We’re building product and service lists for UK companies. Get this one when it’s ready.
Summary
EDGE PHARMACEUTICALS LIMITED is an active private limited company (company number 10581135) incorporated on 24 January 2017, registered in London. Its registered activity is other service activities n.e.c. (SIC 96090). Latest small accounts cover the period ending 30 June 2025, showing net assets of −£206k and cash of £72k, with 0 employees on average. Turnover was £39k and profit for the year £25k. Net assets rose 11% on the prior period (−£231k).
By net assets it sits in the bottom quarter of 16,551 comparable companies in London (median £861, upper quartile £23k).
Ownership and control
- Mr Geoffrey Hugh Melamet
- owns 75–100% of shares
- holds 75–100% of voting rights
- can appoint or remove directors
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
Key dates
- Incorporated
- 24 January 20179 yrs ago
- Next accounts due
- 30 March 2027in 154 days
- Confirmation statement due
- 7 February 2027in 103 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 96090
- Other service activities n.e.c.
- Accounts type
- Total Exemption Full
- Size band
- MicroCompanies Act thresholds
Financials
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 30 June 2025 | −£206k | £72k | £166k | £443k | £39k | £25k | 0 |
| 30 June 2024 | −£231k | £47k | £167k | £445k | £12k | £6,318 | — |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
Filing and accounts signals
- Net assets below zeroNet assets £-205,903 at 30 June 2025
- Net assets up 10% or more on the prior period+10.9% vs prior period
- Current assets below creditors within one yearCurrent ratio 0.54
- Cash at bank of £50,000 or moreCash £71,624
- Incorporated five or more years agoIncorporated 24 January 2017
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
Timeline
- Next accounts duein 154 days
- Confirmation statement duein 103 days
- Accounts period endNet liabilities £206k · small accounts
- Accounts period endNet liabilities £231k · small accounts
- Incorporated
Similar companies in London
- FRANCIS KUMAH LIMITEDLondon · inc. Jan 2017
- ARROW FUTURES (UK) LIMITEDLondon · inc. Jan 2017
- DOG WORLD KENNEL CLUB LTDLondon · inc. Jan 2017
- EIT DIGITAL UKLondon · inc. Jan 2017
- DYNAMIC PROJECT ADVISORY LTDLondon · inc. Jan 2017
- ANDY HIX LTDLondon · inc. Jan 2017
All companies incorporated on 24 January 2017 · in Jan 2017.
Reminders for EDGE PHARMACEUTICALS LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.